Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Aviclear for Hidradenitis Suppurativa (HS)

NCT: NCT06801795 · COMPLETED

NCT IDNCT06801795
StatusCOMPLETED
Start Date2025-02-12
Completion2026-07-21
SponsorUniversity of Miami (OTHER)
First posted
Last updated

Brief Summary

The objective is to evaluate the safety and efficacy of the Cutera 1726 nm laser system (also referred to as AviClear) for the treatment of HS.

Frequently Asked Questions

What is Aviclear for Hidradenitis Suppurativa (HS)?

Aviclear for Hidradenitis Suppurativa (HS) is a clinical trial registered under NCT06801795. Current status: COMPLETED.

What is the status of NCT06801795?

The current status of NCT06801795 (Aviclear for Hidradenitis Suppurativa (HS)) is: COMPLETED.

When did Aviclear for Hidradenitis Suppurativa (HS) start?

Aviclear for Hidradenitis Suppurativa (HS) started on 2025-02-12.

Related Devices

K160488Cutera enlighten III Laser SystemCutera, Inc. K170936Cutera enlighten III Laser SystemCutera, Inc. K172077Cutera enlighten III Laser SystemCutera, Inc. K213461AviClear Laser SystemCutera, Inc. K230660AviClear Laser SystemCutera, Inc.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑